Mission, Pakistan & CV Disease in an Underserved Community

EP 76: Mission, Pakistan & Facing Heart Disease in an Underserved Community

Average (ratings)

No ratings

•

Your rating

Dr Sohail Khan was working as an interventional cardiologist in Salt Lake City, but he was growing more and more skeptical of the corporate aspects of his job. He had a dream about moving back to Pakistan and building a hospital there. Following the death of a colleague, he decided to take a leap.

In this inspiring episode, Dr Ankur Kalra’s guest is Dr Sohail Khan, Chief Operating Officer at the National Institute of Cardiovascular Diseases in Karāchi.

Dr Khan talks about education in the US and his decision to move back to Pakistan. Ankur asks Sohail about his new professional home: NICVD, a free clinic providing primary heartcare for Pakistanis. They discuss some of the innovations Dr Khan works on to improve patient care that utilise simple but effective interventions. We learn more about free screening clinics and about Dr Khan’s work on the largest ever study in Pakistan on association of Lpa and CV disease in South Asians.

What were the considerations for Dr Khan when he decided to move to Pakistan? What is his advice to our listeners?

Questions and comments can be sent to “podcast@radciffe-group.com” and may be answered by Ankur in the next episode. Guest, @SKhanMHCM hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Read MoreRead Less

Episodes

Up Next

ESC 22 in Review With Dr P Parwani: 5 Trials That Will Change Your Practice

Ep 77: ESC 22 in Review With Dr Purvi Parwani: 5 Trials That Will Change Your Practice

EP77 • Sep 26, 2022 • 1h 7m 31s

Back by popular demand, Dr Ankur Kalra's guest is Dr Purvi Parwani, Director of Women’s Cardiovascular Disease Clinic and Assistant Professor at Loma Linda University Medical Center, US. In this ESC 2022 edition of Parallax, Ankur asks Purvi to review her highlights of the congress. Purvi details the study design and key findings of each trial and provides her insights after attending the event in Barcelona. Ankur and Purvi discuss how each trial will inform their practice.

All Episodes

02: Role Of High-Sensitivity Cardiac Troponin In ACS

EP02 • Apr 23, 2020 • 29m 55s

Ankur is back with his second #AudioArticle! This week he spoke with Santiago Garcia from the Minneapolis Heart Institute about Santiago’s US Cardiology Review 13.1 article on the role of high-sensitivity cardiac troponin (hscTn) assays and their ability to rapidly rule in or rule out acute coronary syndrome (ACS) with improved sensitivity.

Chest pain is one of the most common reasons for an emergency room visit in the US, with almost 6 million ER visits annually, yet there is no consensus on how to compare the results from various hscTn assays. Tune in to hear Santiago outline the advantages and limitations of using hscTn as a standard biomarket to evaluate patients with suspected ACS in the ER.

Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.

01: Conduction Abnormalities After TAVR/TAVI With Chad Kliger

EP01 • Apr 23, 2020 • 27m 44s

In our first episode, Ankur explains his vision for and inspiration to start ‘Parallax’, and speaks with Chad Kliger from Lenox Hill Hospital in New York about conduction abnormalities after transcatheter aortic valve replacement (TAVR/TAVI), a review article published in US Cardiology Review 13.1 Ankur and Chad look at conduction abnormalities after TAVR/TAVI with a focus on basic conduction system anatomy in relation to the aortic valve, the mechanism, incidence, predisposing factors for occurrence, impact on mortality and finally, proposed treatment algorithms for management. Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.

... 4 5 6 7 8 9 10 11 12

EP 107: JACC: Advances - Leadership & the Future of Publishing with Dr Silversides

EP107 • Feb 12, 2024 • 43m 21s

Dive into the unique synergy between her clinical practice and editorial leadership as Dr Silversides shares her vision for the journal. Learn how she navigates diverse responsibilities, manages peer reviews, and ensures fair evaluation of the submitted manuscripts. Get insights into launching a journal, from adapting to the needs of the readership and editorial board selection to time management. Dr Silversides joins Dr Kalra in exploring the evolving landscape of academic publishing, discussing the challenges and opportunities presented by AI and other advancements.

EP 106: Transforming Health Systems Through Economics with Dr Alex Carter

EP106 • Jan 29, 2024 • 47m

The podcast embarks on an exploration of the program's three fundamental pillars: health economics, outcomes measurement, and management. Dr. Carter underscores the importance of efficiently allocating scarce resources, evaluating health system performance through population outcomes, and translating theoretical knowledge into practical application through leadership.

EP 105: The Year 2023 in Review with Dr Sukh Nijjer

EP105 • Dec 19, 2023 • 1h 3m 40s

Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.

EP 104: Caring for All Hearts: Disparities in Care with Dr Anuradha Lala

EP104 • Dec 04, 2023 • 44m 2s

In this thought-provoking episode, Dr Ankur Kalra is joined by Dr Anuradha Lala. They delve into the critical topic of disparities in care within the healthcare system from a cardiologist's point of view and explore actionable steps towards a more inclusive and fair healthcare landscape.

This series is supported by ZOLL and is intended for Health Care Professionals.

EP 103: CCS-AMI: New Classification for Acute Myocardial Infarction with Dr Kumar

EP103 • Oct 30, 2023 • 42m 43s

In this informative episode, Dr Kumar shares what led his team and the CCS to introduce a new classification scheme for acute MI. He discusses how research from the past 15 years highlighted the need to incorporate tissue changes resulting from acute myocardial infarction (MI) into clinical practice. Dr Kumar outlines the four stages of CCS-AMI, and we gain insight into how this novel classification scheme could impact bedside medicine.

1 2 3 4 5 6 ...